Medifast's balance sheet remains strong with cash, cash equivalents, and investment securities of $157.8 million and no interest-bearing debt as of September 30, 2023. The company also announced a quarterly cash dividend of $1.65 per share, payable on November 7, 2023, to stockholders of record as of the close of business on September 19, 2023.